OBJECTIVE: The aims of this secondary analysis of the "Colpopexy And Urinary Reduction Efforts" (CARE) study were to estimate the incidence of postoperative gastrointestinal complications and identify risk factors. STUDY DESIGN: We prospectively identified gastrointestinal complications and serious adverse events (SAE) for 12 months after sacrocolpopexy. Two surgeons independently reviewed reports of ileus or small bowel obstruction (SBO). RESULTS: Eighteen percent of 322 women (average age 61.3 years) reported "nausea, emesis, bloating, or ileus" during hospitalization and 9.8% at 6 weeks. Nineteen women (5.9%; CI 3.8%, 9.1%) had a possible ileus or SBO that generated SAE reports: 4 (1.2%, CI 0.5%,3.2%) were reoperated for SBO, 11 (3.4%, CI 1.9%,6.1%) were readmitted for medical management, and 4 had a prolonged initial hospitalization. Older age (P < .001) was a risk factor for ileus or SBO. CONCLUSION: One in 20 women experiences significant gastrointestinal morbidity after sacrocolpopexy. This information will aid preoperative counseling.
OBJECTIVE: The aims of this secondary analysis of the "Colpopexy And Urinary Reduction Efforts" (CARE) study were to estimate the incidence of postoperative gastrointestinal complications and identify risk factors. STUDY DESIGN: We prospectively identified gastrointestinal complications and serious adverse events (SAE) for 12 months after sacrocolpopexy. Two surgeons independently reviewed reports of ileus or small bowel obstruction (SBO). RESULTS: Eighteen percent of 322 women (average age 61.3 years) reported "nausea, emesis, bloating, or ileus" during hospitalization and 9.8% at 6 weeks. Nineteen women (5.9%; CI 3.8%, 9.1%) had a possible ileus or SBO that generated SAE reports: 4 (1.2%, CI 0.5%,3.2%) were reoperated for SBO, 11 (3.4%, CI 1.9%,6.1%) were readmitted for medical management, and 4 had a prolonged initial hospitalization. Older age (P < .001) was a risk factor for ileus or SBO. CONCLUSION: One in 20 women experiences significant gastrointestinal morbidity after sacrocolpopexy. This information will aid preoperative counseling.
Authors: M D Miller; C F Paradis; P R Houck; S Mazumdar; J A Stack; A H Rifai; B Mulsant; C F Reynolds Journal: Psychiatry Res Date: 1992-03 Impact factor: 3.222
Authors: Linda Brubaker; Geoff Cundiff; Paul Fine; Ingrid Nygaard; Holly Richter; Anthony Visco; Halina Zyczynski; Morton B Brown; Anne Weber Journal: Control Clin Trials Date: 2003-10
Authors: Ingrid E Nygaard; Rebecca McCreery; Linda Brubaker; AnnaMarie Connolly; Geoff Cundiff; Anne M Weber; Halina Zyczynski Journal: Obstet Gynecol Date: 2004-10 Impact factor: 7.661
Authors: Susan L Hendrix; Amanda Clark; Ingrid Nygaard; Aaron Aragaki; Vanessa Barnabei; Anne McTiernan Journal: Am J Obstet Gynecol Date: 2002-06 Impact factor: 8.661
Authors: Miles Murphy; Adam Holzberg; Heather van Raalte; Neeraj Kohli; Howard B Goldman; Vincent Lucente Journal: Int Urogynecol J Date: 2011-11-16 Impact factor: 2.894
Authors: Manhan K Vu; Juraj Letko; Kelly Jirschele; Adam Gafni-Kane; Aimee Nguyen; Honyan Du; Roger P Goldberg Journal: Int Urogynecol J Date: 2012-04-25 Impact factor: 2.894
Authors: Jessica C Sassani; Kelly Kantartzis; Liwen Wu; Anthony Fabio; Halina M Zyczynski Journal: Int Urogynecol J Date: 2019-11-26 Impact factor: 2.894
Authors: Daniel Altman; Tomi S Mikkola; Karl Möller Bek; Päivi Rahkola-Soisalo; Jonas Gunnarsson; Marie Ellström Engh; Christian Falconer Journal: Int Urogynecol J Date: 2016-02-13 Impact factor: 2.894